Bolt Biotherapeutics Names Sheila Gujrathi Chief Strategy Officer

Bitget2026/10/23 13:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Bolt Biotherapeutics named Sheila Gujrathi chief strategy officer and a board member following its acquisition of Prana Therapies.
Gujrathi is Prana's co-founder and former chief executive officer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bolt Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610230908PRIMZONEFULLFEED9851994) on October 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Bolt Biotherapeutics Names Sheila Gujrathi Chief Strategy Officer

You may also like

Crypto prices